San Diego, CA, United States of America

Chen Wang Liaw

USPTO Granted Patents = 35 


Average Co-Inventor Count = 4.2

ph-index = 10

Forward Citations = 548(Granted Patents)


Company Filing History:


Years Active: 1996-2015

Loading Chart...
Loading Chart...
35 patents (USPTO):Explore Patents

Title: Innovations in Obesity and Atherogenesis: The Contributions of Chen Wang Liaw

Introduction

Chen Wang Liaw is a prolific inventor based in San Diego, California, holding an impressive 35 patents. His research primarily focuses on innovative methods to combat obesity and related health conditions. His inventions utilize the mechanisms of G protein-coupled receptors to develop therapeutic agents, demonstrating significant advancements in medical science.

Latest Patents

Among Chen Wang Liaw's notable contributions are his latest patents focused on identifying candidate compounds related to the human G protein-coupled receptor (GPCR), GPR50. One of his patents describes methods to screen for compounds that serve as modulators of body mass or adiposity, targeting obesity and its associated conditions, including hypertension and Type 2 diabetes.

Another significant patent outlines the methods for screening compounds that reduce atherogenesis, emphasizing the GPCR's role in identifying potential therapeutic agents for atherosclerosis and atherosclerotic diseases. These inventions pave the way for new treatments and preventative measures for serious health conditions linked to metabolic and cardiovascular issues.

Career Highlights

Chen Wang Liaw has had a distinguished career, working with esteemed companies such as Arena Pharmaceuticals, Inc. and Neurocrine Biosciences, Inc. His contributions to the fields of pharmacology and biotechnology have set new standards and opened new avenues for research and development in drug therapy.

Collaborations

Throughout his career, Chen has collaborated with notable figures in the industry, including Derek T Chalmers and Dominic P Behan. These collaborations have fostered an environment of innovation, allowing for the sharing of ideas and advancing research in crucial areas of health and disease management.

Conclusion

In summary, Chen Wang Liaw's inventions and patents are significant contributions to the medical field, particularly in addressing obesity and cardiovascular diseases. His dedication to research and innovation not only reflects his expertise as an inventor but also highlights the potential for new therapeutic options in the fight against prevalent health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…